Tirzepatide GLP-1/GIP: dual action for weight management
Educational information about tirzepatide. This does not constitute medical advice. Always consult with a licensed provider.
See if I qualify for evaluation
Important notice: This information is educational only and does not constitute medical advice. The use of any medication requires evaluation and prescription by a licensed healthcare provider. Results vary. Not all patients qualify.
01What is tirzepatide?
Tirzepatide is an injectable medication that acts on two types of receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1. This dual action differentiates it from single GLP-1 agonists like semaglutide. It has been studied in the context of metabolic control and weight management under medical supervision. Well-known brands include Mounjaro® and Zepbound®.
02How does the dual GLP-1/GIP action work?
By activating both GIP and GLP-1 receptors, tirzepatide may have a synergistic effect on appetite regulation, glucose metabolism, and weight loss. Clinical studies have shown significant results, although effects vary considerably between individuals. Only a licensed provider can determine if it is appropriate for your situation.
03Who might be a candidate?
Eligibility for tirzepatide treatment is determined exclusively by a licensed healthcare provider. It is generally considered for adults with a BMI of 27 or higher with weight-related conditions, or a BMI of 30 or higher. Your complete medical history, current medications, and existing conditions are critical factors in this determination. Not all patients qualify.
04How is it administered?
Compounded tirzepatide is typically administered via subcutaneous injection once per week. The specific dosing plan is determined by the licensed healthcare provider. Generally, treatment starts with a low dose that may be adjusted over time based on the patient's response and tolerance.
05Common side effects
The most frequently reported side effects include nausea, diarrhea, vomiting, and decreased appetite, especially during the first weeks of treatment. Most of these effects tend to decrease over time. It is essential to discuss all risks with your licensed provider before starting any treatment.
06Compounded vs. branded tirzepatide
As with semaglutide, compounded versions of tirzepatide are available through certified compounding pharmacies. These are different from FDA-approved medications such as Mounjaro® or Zepbound®. Consult with your licensed provider about available options and their specific differences for your case.
Quick facts about tirzepatide
GLP-1/GIP Dual
Class
Subcutaneous injection
Administration
Once per week
Frequency
Requires provider
Prescription
Tirzepatide or Semaglutide?
Both are GLP-1 agonists. Tirzepatide also acts on GIP receptors. A licensed provider will help you determine which is more appropriate for your situation.
See full comparisonYour journey starts with an evaluation
2 minutes. No commitment. In your language.
Check my eligibilityIf eligible and approved. Licensed provider review required. Results vary.